| Financial Year |
March 31 2023 |
| Monetary Funds |
185,003,250.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,399,969.20 |
| Accounts Receivable |
351,242,048.80 |
| Advances to Suppliers |
37,517,367.05 |
| Other Receivables |
20,859,704.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
120,257,441.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
25,310,778.03 |
| Other Current Assets |
18,442,077.06 |
| Total Current Assets |
1,076,003,604.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,754,357.89 |
| Long-term Equity Investment |
2,411,376.97 |
| Investment Properties |
-- |
| Fixed Assetes |
81,323,645.64 |
| Under-construction Projects |
48,223,003.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,443,285.09 |
| R&D expenses |
44,422,393.82 |
| Goodwill |
942,906.95 |
| Long-Term Deferred and Prepaid Expenses |
2,074,262.64 |
| Deferred Income Tax Assets |
21,637,272.67 |
| Other Non-Current Assets |
24,632,256.12 |
| Sub-Total of Non-Current Assets |
261,994,128.02 |
| Total Assets |
1,337,997,732.72 |
| Short-Term Loans |
163,532,237.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
60,310,377.24 |
| Accounts Payable |
185,033,246.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,756,402.20 |
| Taxes Payable |
1,650,082.00 |
| Interest Payable |
307,029.87 |
| Dividend Payable |
-- |
| Other payables |
1,517,663.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
513,728.39 |
| Other Current Liabilities |
38,035,697.32 |
| Sub-Total of Current Liabilities |
541,298,761.37 |
| Long-term Loans |
-- |
| Bonds Payable |
215,431,551.56 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
216,729,253.36 |
| Total Liabilities |
758,028,014.73 |
| Paid-In Capital(Or Share Stock) |
164,462,984.00 |
| Capital Surplus |
164,904,027.26 |
| Surplus Reserve |
25,090,023.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
197,971,864.42 |
| Minority Stockholder's Interest |
3,558,326.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
576,411,391.22 |
| Owner's Equity（Stockholder's Equity） |
579,969,717.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,337,997,732.72 |
